197 related articles for article (PubMed ID: 28294542)
1. PRAS40 alleviates neurotoxic prion peptide-induced apoptosis via mTOR-AKT signaling.
Yang W; Yang LF; Song ZQ; Shah SZA; Cui YY; Li CS; Zhao HF; Gao HL; Zhou XM; Zhao DM
CNS Neurosci Ther; 2017 May; 23(5):416-427. PubMed ID: 28294542
[TBL] [Abstract][Full Text] [Related]
2. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.
Vander Haar E; Lee SI; Bandhakavi S; Griffin TJ; Kim DH
Nat Cell Biol; 2007 Mar; 9(3):316-23. PubMed ID: 17277771
[TBL] [Abstract][Full Text] [Related]
3. PRAS40 plays a pivotal role in protecting against stroke by linking the Akt and mTOR pathways.
Xiong X; Xie R; Zhang H; Gu L; Xie W; Cheng M; Jian Z; Kovacina K; Zhao H
Neurobiol Dis; 2014 Jun; 66():43-52. PubMed ID: 24583056
[TBL] [Abstract][Full Text] [Related]
4. PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis.
Thedieck K; Polak P; Kim ML; Molle KD; Cohen A; Jenö P; Arrieumerlou C; Hall MN
PLoS One; 2007 Nov; 2(11):e1217. PubMed ID: 18030348
[TBL] [Abstract][Full Text] [Related]
5. PRAS40 is an integral regulatory component of erythropoietin mTOR signaling and cytoprotection.
Chong ZZ; Shang YC; Wang S; Maiese K
PLoS One; 2012; 7(9):e45456. PubMed ID: 23029019
[TBL] [Abstract][Full Text] [Related]
6. Proline-rich AKT substrate of 40-kDa (PRAS40) in the pathophysiology of cancer.
Malla R; Ashby CR; Narayanan NK; Narayanan B; Faridi JS; Tiwari AK
Biochem Biophys Res Commun; 2015 Jul; 463(3):161-6. PubMed ID: 26003731
[TBL] [Abstract][Full Text] [Related]
7. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
Mi W; Ye Q; Liu S; She QB
Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827
[TBL] [Abstract][Full Text] [Related]
8. Role of PRAS40 in Akt and mTOR signaling in health and disease.
Wiza C; Nascimento EB; Ouwens DM
Am J Physiol Endocrinol Metab; 2012 Jun; 302(12):E1453-60. PubMed ID: 22354785
[TBL] [Abstract][Full Text] [Related]
9. HDAC6 alleviates prion peptide-mediated neuronal death via modulating PI3K-Akt-mTOR pathway.
Zhu T; Zhao D; Song Z; Yuan Z; Li C; Wang Y; Zhou X; Yin X; Hassan MF; Yang L
Neurobiol Aging; 2016 Jan; 37():91-102. PubMed ID: 26507311
[TBL] [Abstract][Full Text] [Related]
10. Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation.
Wang L; Harris TE; Lawrence JC
J Biol Chem; 2008 Jun; 283(23):15619-27. PubMed ID: 18372248
[TBL] [Abstract][Full Text] [Related]
11. Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1.
Völkers M; Toko H; Doroudgar S; Din S; Quijada P; Joyo AY; Ornelas L; Joyo E; Thuerauf DJ; Konstandin MH; Gude N; Glembotski CC; Sussman MA
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12661-6. PubMed ID: 23842089
[TBL] [Abstract][Full Text] [Related]
12. Genetic ablation of PRAS40 improves glucose homeostasis via linking the AKT and mTOR pathways.
Malla R; Wang Y; Chan WK; Tiwari AK; Faridi JS
Biochem Pharmacol; 2015 Jul; 96(1):65-75. PubMed ID: 25931147
[TBL] [Abstract][Full Text] [Related]
13. Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway.
Havel JJ; Li Z; Cheng D; Peng J; Fu H
Oncogene; 2015 Mar; 34(12):1487-98. PubMed ID: 24704832
[TBL] [Abstract][Full Text] [Related]
14. Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism.
Caccamo A; Maldonado MA; Majumder S; Medina DX; Holbein W; Magrí A; Oddo S
J Biol Chem; 2011 Mar; 286(11):8924-32. PubMed ID: 21266573
[TBL] [Abstract][Full Text] [Related]
15. PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells.
Zhang F; Beharry ZM; Harris TE; Lilly MB; Smith CD; Mahajan S; Kraft AS
Cancer Biol Ther; 2009 May; 8(9):846-53. PubMed ID: 19276681
[TBL] [Abstract][Full Text] [Related]
16. Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k/Akt signaling pathway.
Wang H; Zhang Q; Wen Q; Zheng Y; Lazarovici P; Jiang H; Lin J; Zheng W
Cell Signal; 2012 Jan; 24(1):17-24. PubMed ID: 21906675
[TBL] [Abstract][Full Text] [Related]
17. Prion formation correlates with activation of translation-regulating protein 4E-BP and neuronal transcription factor Elk1.
Allard EK; Grujic M; Fisone G; Kristensson K
Neurobiol Dis; 2013 Oct; 58():116-22. PubMed ID: 23742760
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of PRAS40(T246A) in the Proliferative Compartment Suppresses mTORC1 Signaling, Keratinocyte Migration, and Skin Tumor Development.
Rho O; Srivastava J; Cho J; DiGiovanni J
J Invest Dermatol; 2016 Oct; 136(10):2070-2079. PubMed ID: 27349859
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of a proline-rich Akt substrate (PRAS40) in human copper/zinc-superoxide dismutase transgenic rats protects motor neurons from death after spinal cord injury.
Yu F; Narasimhan P; Saito A; Liu J; Chan PH
J Cereb Blood Flow Metab; 2008 Jan; 28(1):44-52. PubMed ID: 17457363
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of PRAS40 on Thr246 by PKB/AKT facilitates efficient phosphorylation of Ser183 by mTORC1.
Nascimento EB; Snel M; Guigas B; van der Zon GC; Kriek J; Maassen JA; Jazet IM; Diamant M; Ouwens DM
Cell Signal; 2010 Jun; 22(6):961-7. PubMed ID: 20138985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
